Skip to main content
. 2019 Apr-Jun;8(2):75–82. doi: 10.4103/jrpp.JRPP_18_78

Table 1.

Patients’ characteristics of Vitamin C and control groups

Characteristics Control group (n=126) Vitamin C group (n=126) P
Age (years) 57.18±10.4 58.64±10.41 0.26*
Sex (male) n (%) 104 (82.5) 97 (76.9) 0.27**
Presence of cardiovascular risk factors
 Diabetes mellitus, n (%) 42 (33.33) 50 (39.68) 0.29**
 Hypertension, n (%) 52 (41.26) 56 (44.44) 0.61**
 Smoking, n (%) 50 (39.68) 53 (42.06) 0.70**
 Hyperlipidemia, n (%) 21 (16.66) 29 (23.01) 0.20**
 Family history, n (%) 24 (19) 13 (10.3) 0.05**
Ischemic heart disease, n (%) 5 (3.96) 15 (11.90) 0.02**
Volume of infused contrast media (ml) 228±69 227±63 0.52*
Types of iodine-based contrast media
 Ultravist, n (%) 6 (4.76) 6 (4.76) 1**
 Visipaque, n (%) 120 (95.23) 120 (95.23)
Ejection fraction (%) 41.37±7.77 43.00±6.83 0.09*
Serum creatinine (mg/dL) 0.93±0.2 0.94±0.23 0.63*
Number of diseased vessels (n)
 One vessel 58 43 0.13**
 Two vessels 45 50
 Three vessels 23 33

*Resulted from twoindependent samples t-test, **Resulted from Chi-square test. Data presented as mean±SD, or n and percent of the patients. SD=Standard deviation